Human FGF-4, C-His Tag

Catalog number HA210946-01

Choose a variant (3 options)

Selecting a variant updates its price, size and availability.

Price for HA210946-01

Size / count 20 µg

Specifications

Catalog number: HA210946-01
Size / count: 20 µg
Dry ice: No
Hazardous: No
Discontinued: No
Species Reactivity: Human
Type: Protein
Purity: >95% as determined by SDS-PAGE
Form: Lyophilized
Storage Conditions: Please avoid repeated freeze-thaw cycles. Samples are stable for up to twelve months from date of receipt at -20°C to -80°C It is recommended that aliquot the reconstituted solution to minimize freeze-thaw cycles.

Frequently Asked Questions

What is the catalog number for Human FGF-4, C-His Tag?

The catalog number for Human FGF-4, C-His Tag is HA210946.

What sizes are available for Human FGF-4, C-His Tag?

Human FGF-4, C-His Tag is available in the following size(s): 20 µg, 50 µg, 100 µg.

How many pack sizes does Human FGF-4, C-His Tag come in?

Human FGF-4, C-His Tag is available in 3 different pack sizes.

Is Human FGF-4, C-His Tag in stock?

Human FGF-4, C-His Tag is currently made to order / not held in immediate stock. Contact us for lead time.

What is the shelf life of this product?

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

What expression system was used for this recombinant protein?

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Can I return this product if I ordered the wrong one?

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.